Literature DB >> 22004880

Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.

Robert P Baughman, Marc A Judson, Rebecca Ingledue, Nicole L Craft, Elyse E Lower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22004880     DOI： 10.1001/archdermatol.2011.301

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  21 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

Review 2.  Nonsteroidal therapy of sarcoidosis.

Authors:  Peter Korsten; Mehdi Mirsaeidi; Nadera J Sweiss
Journal:  Curr Opin Pulm Med       Date:  2013-09       Impact factor: 3.155

Review 3.  Apremilast: first global approval.

Authors:  Raewyn M Poole; Anita D Ballantyne
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

Review 4.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

5.  Inter-rater reliability of cutaneous sarcoidosis assessment tools via remote photographic assessment.

Authors:  Sara A Berg; Howa Yeung; Joseph C English; Emily L Keimig; Ellen J Kim; Robert G Micheletti; Karolyn A Wanat; Marc A Judson; Robert P Baughman; Misha Rosenbach
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 6.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 7.  [Sarcoidosis : Dermatological view of a rare multisystem disease].

Authors:  T Giner; S Benoit; H Kneitz; M Goebeler
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

Review 8.  New molecular targets for the treatment of sarcoidosis.

Authors:  Jared Chiarchiaro; Bill B Chen; Kevin F Gibson
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

9.  Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.

Authors:  Misha Rosenbach; Howa Yeung; Emily Y Chu; Ellen J Kim; Aimee S Payne; Junko Takeshita; Carmela C Vittorio; Karolyn A Wanat; Victoria P Werth; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

Review 10.  Phosphodiesterase 4-targeted treatments for autoimmune diseases.

Authors:  Neal Kumar; Ari M Goldminz; Noori Kim; Alice B Gottlieb
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.